title: Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
authors.affiliation: Department of Dermatology, Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea.
authors.forename: Mi Sun
authors.initials: MS
authors.lastname: Kim
authors.forename: Seo Wan
authors.initials: SW
authors.lastname: Kim
authors.forename: Tae Young
authors.initials: TY
authors.lastname: Han
authors.forename: Sook Ja
authors.initials: SJ
authors.lastname: Son
authors.forename: June Hyunkyung
authors.initials: JH
authors.lastname: Lee
authors.forename: Eui-Joong
authors.initials: EJ
authors.lastname: Kim
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy; D063926:Drug Hypersensitivity Syndrome / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D010879:Piperazines / Q000009:adverse effects*; D012008:Recurrence; D019233:Retreatment; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone